Internal Medicine, Cardiovascular Disease · Plantation, FL
NPI
1619084456
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
350 NW 84th Ave Ste 211
Plantation, FL, 33324
Phone (954) 236-8511
Groups this clinician bills Medicare through
Medicare paid, 2024
$431K
5,729 services
Medicare patients, 2024
1,086
Average age 77
Drug cost, 2024
$1.5M
12,324 prescriptions
Company payments, 2025
$2,206
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Steiman was code 99214 (office e&m - established), 1,086 times for 621 patients. In total David M Steiman billed 5,729 services in 43 codes, and Medicare paid $431K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,086 | 621 | $99.83 | $108K |
| 93000 Electrocardiogram | Office | 1,078 | 745 | $11.20 | $12K |
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 1,024 | 21 | $0.39 | $398 |
| 93306 Echocardiography (TTE/TEE) | Office | 448 | 421 | $142.10 | $64K |
| 99215 Office E&M - Established | Office | 299 | 228 | $145.73 | $44K |
| 93010 Electrocardiogram | Facility | 260 | 178 | $6.29 | $1,636 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 174 | 173 | $150.64 | $26K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 144 | 72 | $189.53 | $27K |
| 99442 Telephone Services | Office | 108 | 98 | $74.63 | $8,060 |
| 99205 Office E&M - New | Office | 86 | 86 | $168.31 | $14K |
| 93015 Electrocardiogram | Office | 75 | 75 | $52.86 | $3,965 |
| 99204 Office E&M - New | Office | 73 | 73 | $121.14 | $8,843 |
| 78452 Myocardial Perfusion Scan | Office | 72 | 72 | $350.95 | $25K |
| 93306 Echocardiography (TTE/TEE) | Facility | 71 | 69 | $52.23 | $3,708 |
| 93228 Electrocardiogram | Office | 68 | 68 | $21.46 | $1,459 |
By year: 2022 $378K for 6,142 services; 2023 $409K for 6,105 services; 2024 $431K for 5,729 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 65 | 22 | $4.20 | $273 |
Medicare prescription drug claims, 2024
In 2024, the drug David M Steiman prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,062 prescriptions and refills. In total David M Steiman wrote 12,324 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,062 | 2,907 | 353 | $12K |
| Metoprolol Succinate Generic | 948 | 2,301 | 313 | $9,710 |
| Amlodipine Besylate Generic | 623 | 1,710 | 194 | $4,268 |
| Olmesartan Medoxomil Generic | 610 | 1,693 | 206 | $12K |
| Atorvastatin Calcium Generic | 516 | 1,375 | 154 | $4,523 |
| Eliquis Apixaban | 452 | 756 | 92 | $425K |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 434 | 1,128 | 129 | $15K |
| Losartan Potassium Generic | 293 | 778 | 88 | $2,292 |
| Atenolol Generic | 293 | 787 | 77 | $1,841 |
| Spironolactone Generic | 282 | 770 | 103 | $2,885 |
| Clopidogrel Clopidogrel Bisulfate | 246 | 630 | 70 | $2,459 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 231 | 565 | 61 | $5,960 |
| Torsemide Generic | 205 | 470 | 75 | $2,992 |
| Xarelto Rivaroxaban | 188 | 315 | 41 | $173K |
| Labetalol Hcl Generic | 183 | 455 | 54 | $3,396 |
Brand drugs: 1,671 claims; generic drugs: 10,634 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Steiman $2,206 ($2,206 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $365.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 25 | $365 |
| Novo Nordisk Inc NVO | 14 | $339 |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $235 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $207 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $193 |
| Boston Scientific Corporation BSX | 7 | $193 |
| Amgen Inc. AMGN | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83.97 |
| Merck Sharp & Dohme LLC MRK | 3 | $83.14 |
| Pfizer Inc. PFE | 3 | $71.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.